Win-Partners Co

Win-Partners Co Buyback Yield

The Buyback Yield of Win-Partners Co (3183.T) as of Nov 3, 2026 is 3.73 %. In the previous year, Buyback Yield was 1.03 % — a change of 260.93% (higher).

Buyback Yield

3.73 %

YoY

260.93%

Last updated:

Buyback Yield of Win-Partners Co is 2026 3.73 % . Buyback Yield of Win-Partners Co was 2025 1.03 % . It decreases by 260.93% higher compared to the previous year.

The Win-Partners Co Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2019
0.00 JPY
Jan 1, 2020
0.00 JPY
Jan 1, 2021
0.77 JPY
Jan 1, 2022
0.77 JPY
Jan 1, 2023
0.00 JPY
Jan 1, 2024
0.00 JPY
Jan 1, 2025
1.03 JPY
Jan 1, 2026
3.73 JPY
The Win-Partners Co Buyback Yield history
YEARBuyback YieldYoY
3.73 %+260.93%
1.03 %+39.79 M%
0.00—
0.00-100.00%
0.77 %0.00%
0.77 %—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Win-Partners Co Stock analysis

What does Win-Partners Co do? WIN-Partners Co., Ltd. generates revenue through the management of its group of companies specializing in medical device sales. The company offers catheters for ischemic heart disease, pacemakers for cardiac rhythm management, artificial blood vessels for cardiovascular surgery, and embolization coils for peripheral vascular disease and brain surgery. Additionally, it provides large-scale medical equipment including computed tomography (CT) systems for radiology departments and operating rooms. Its primary customers are healthcare institutions requiring advanced medical technology solutions. The company's product portfolio targets specific medical specialties, with catheters, pacemakers, and artificial blood vessels serving cardiovascular applications. Embolization coils address vascular and neurological procedures, while CT equipment supports diagnostic imaging needs across various hospital departments. These offerings are distributed through the company's managed group of medical device sales entities. WIN-Partners focuses on high-value medical devices that require specialized sales channels and technical support. Its business model centers on managing a network of companies that handle the distribution and sales of these medical technologies to hospitals and clinics. The firm's revenue streams are derived from the sale of these specialized medical devices and equipment to healthcare providers in Japan and potentially international markets. Win-Partners Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Win-Partners Co stock

Buyback Yield of Win-Partners Co is 3.73 % in 2026.

Buyback Yield of Win-Partners Co changed from 1.03 % to 3.73 %, representing a 260.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Buyback Yield Win-Partners Co since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Win-Partners Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Win-Partners Co

All Key Metrics — Win-Partners Co